Guidance

Batch testing medicines if there's no Brexit deal

How batch testing medicines would be affected if the UK leaves the EU with no deal.

• From: Department of Health and Social Care
• Published: 23 August 2018
• Last updated: 14 September 2018
  Show all updates

  1. 14 September 2018

     Updated to inform that the notices may sometimes apply to businesses and citizens in the EEA.

  2. 23 August 2018

     First published.

This publication was withdrawn on 17 July 2019

This guidance has been superseded by ‘Businesses supplying medicines and medical devices – what to expect on day one of a ‘no deal’ scenario’.

Documents

Batch testing medicines if there’s no Brexit deal

HTML

Details

If the UK leaves the EU without a deal, we’ll continue to:

• accept batch testing of human medicines carried out in countries on a list from the Medicines and Healthcare products Regulatory Agency (MHRA)
• require a UK, EU or EEA-based qualified person (QP) to certify batch testing